Dual PI3K/mTOR inhibitors have displayed significant, concentration-dependent cell proliferation inhibition and induction of apoptosis in a broad panel of cancer cell lines, including those harboring PI3K p110α activating mutations [224]. Here, MTOR is linked to cancer.